drugset / Trial / NCT00000298
Buprenorphine Combination Tablet Feasibility - 1
Double-blindTreatment
Summary
The purpose of this study is to determine target dose range of buprenorphine/naloxone combination tablet that provides therapeutic response in opiate addicts with low to moderate dependence, and to identify appropriate initial induction dose in opiate addicts with low to moderate dependence."
Timeline
- Start
- 1995-08
- Primary completion
- —
- Completion
- —
Publications
- Background Buprenorphine/nalaxone cmbination tablet: First clinical experience (j. Add Dis 1997, in press). Buprenorphine/naloxone combination tablet: First clincial experience (J Add Dis 1997, in press).
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buprenorphine | Other / unclassified | — | — |
| Subject | Naloxone | Small molecule | — | — |